PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers. Hulse M, Wang M, Xu C, Carter J, et al. Cancer Res 2026;86:213-235.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hulse M, Wang M, Xu C, Carter J, et al. PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers. Cancer Res 2026;86:213-235.
PMID: 40991405